about
Hepatitis E Seroprevalence in Europe: A Meta-AnalysisChronic hepatitis e virus infection and treatmentReview article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.Hepatitis E virus: Emerging from the shadows in developed countries.Extrahepatic manifestations of hepatitis E virus.A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries.Hepatitis E virus in patients with acute severe liver injury.Hepatitis E virus and neurologic disorders.Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant.Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation.Cryptic Hepatitis B and E in Patients With Acute Hepatitis of Unknown Etiology.Two Generations of "Gold Standards": The Impact of a Decade in Hepatitis E Virus Testing Innovation on Population SeroprevalenceCharacterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.Predictive value of symptoms and demographics in diagnosing malignancy or peptic stricture.Investigating occult gastrointestinal haemorrhage.The role of hepatitis E virus testing in drug-induced liver injury.Hepatitis E virus in developed countries: one of the most successful zoonotic viral diseases in human history?Hepatitis E: an emerging infection in developed countries.Hepatitis E virus: Western Cape, South Africa.Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study.Neuralgic amyotrophy and hepatitis E virus infection.Hepatitis e: the 'new kid on the block' or an old friend?Can patients determine the level of their dysphagia?Changing Epidemiology of Hepatitis A and Hepatitis E Viruses in China, 1990-2014.Host risk factors and autochthonous hepatitis E infection.Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis.Hepatitis E: source and route of infection, clinical manifestations and new developments.Autochthonous hepatitis E in developed countries and HEV/HIV coinfection.Hepatitis E: An emerging infection in high income countries.The natural history of autoimmune hepatitis presenting with jaundice.Hepatitis E virus and neurological injury.Hepatitis E Virus Infects Neurons and Brains.Detection of viral hepatitis E in clinical liver biopsies.Treatment of hepatitis E virus.Hepatitis E virus and neurological disorders.Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15.Hepatitis E Virus: Time to Change the Textbooks.Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy.Abdominal distension and low grade fever in a refugee from Sudan.Coastal clustering of HEV; Cornwall, UK.
P50
Q26742017-BDEE85E5-3DC0-403A-AF46-4BDA731C0B29Q26996422-45C9F129-1461-42DB-8C45-5B9A3975BBFDQ30234629-E7228CDF-6858-4FB9-BC73-47A22DBB916DQ30241303-7237E388-76CC-41E1-A944-C651E9E5A9A8Q33430954-28ED2A50-2DED-418F-811D-0E252FD0DFE9Q33545709-111541C8-39C2-4B2D-81FA-44784981F10DQ33845158-3322B55B-1E31-47F7-AE0D-1D62FDFD540EQ34025611-8D3F6F62-C9FD-45F5-8AD5-D90C2F2EB51DQ34572927-58F18E5F-CA76-4030-871F-D8FF5A3F91BBQ34906599-73B1506E-B62A-4F1D-95C3-E7FCB565D8BCQ35686350-A4E3B572-4EA2-434C-8FE2-DC3D5D7307C2Q36131945-3BA525BF-FAFF-46A4-B358-3C44CD536EDCQ36134262-691EB8E8-6B01-4012-96BF-93288052653BQ36215525-1E63E824-9766-43E5-825D-AA2BAA87A321Q36755854-8DCEFC2C-E168-412F-BD23-9D9AE6717D36Q36938489-263AF5B5-A8CC-45CB-9F18-FC5B2B4C5CEAQ37098206-6A049F41-87D1-4723-8FF4-CBFC1F527398Q37320904-B3EA6892-D833-4A34-BA00-25F338E392B8Q37444294-A4F59AFD-451E-44BE-B8F8-0C259040FDEFQ37567350-B0EE7C86-1019-4732-883B-61CCDBB1BD30Q37608880-76B79CC6-82F2-4560-AA0E-295110C437C4Q37630307-A307FAC6-75E6-40E0-A694-67EBB9B2FF8FQ37643986-875C178B-535F-46BE-A396-59C1259006D8Q37664349-901FB5E8-4E0C-4C79-90E8-5A5E81AFBEB0Q37937407-209370E0-ACC7-4681-9F8D-C76CC4B3505BQ38007217-2471BA91-5A87-47DC-8A7D-39A98881E88FQ38066540-2A44F6E5-9444-4CC6-B10C-FC080E789A6FQ38096972-2883F33A-03B0-42BB-8308-8A1B81DE6FE9Q38175583-303C3DCB-80BD-40D7-B5B8-7D64E067862CQ38201575-9F9402D1-6B30-4A67-B008-64582CC6841DQ38681788-DCE1F7B2-33E0-4DB3-95E2-561330B02D46Q38716400-9336CEF9-1F69-4D62-A878-50AAABE638D9Q38764392-2580F65B-A079-45A3-AF20-B0060A47F071Q38949492-0D5F1B3F-0906-4A66-A61E-9C716CBB55A5Q39396627-7BF60D92-5FFC-4874-8199-8D75D32EB08AQ39619400-C6358B76-A723-4EAF-BAED-D7EA7EED794CQ39773374-A7543E1F-06BE-4292-A6C6-51E8C11FCD54Q40097605-AFAA5B7D-286B-4C04-A0DE-63E92BDCEF7EQ40410017-8EC72DDF-CE22-4D2E-AF95-6B1AADC5633CQ40855246-107F8B73-4380-4886-917B-0465FD977179
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Harry R Dalton
@ast
Harry R Dalton
@en
Harry R Dalton
@es
Harry R Dalton
@nl
Harry R Dalton
@sl
type
label
Harry R Dalton
@ast
Harry R Dalton
@en
Harry R Dalton
@es
Harry R Dalton
@nl
Harry R Dalton
@sl
prefLabel
Harry R Dalton
@ast
Harry R Dalton
@en
Harry R Dalton
@es
Harry R Dalton
@nl
Harry R Dalton
@sl
P1006
P214
P1006
P106
P21
P214
P31
P496
0000-0001-7786-5457
P734
P735
P7859
lccn-n89108865